<?xml version="1.0"?>

<document>
	<title>Pseudomonas aeruginosa infection in cystic fibrosis.  Bactericidal
   effect of serum from normal individuals and patients with cystic
   fibrosis on P. aeruginosa strains from patients with cystic fibrosis
   or other diseases.</title>

	<author>Holby-N.</author>
	<author>Olling-S.</author>

	<source>Acta-Pathol-Microbiol-Scand [C]. 1977 Apr. 85(2). P 107-14.</source>

	<abstract>P. aeruginosa strains originating from the respiratory tract of
   patients with cystic fibrosis (CF) and patients with other diseases
   (non-CF) were analysed with regard to their sensitivity to the
   bactericidal activity of human serum. P. aeruginosa strains isolated
   from CF patients were more sensitive than strains from non-CF
   patients to the bactericidal activity of normal human serum. The
   bactericidal activity was heatlabile. As regards the sensitivity to
   normal human serum, mucoid and non-mucoid variants were not found to
   differ. Strains originating from chronically infected CF patients
   with many precipitins against these bacteria did not differ with
   respect to serum sensitivity from strains originating from
   intermittently colonized CF patients without P. aeruginosa
   precipitins. Compared with normal sera, CF sera showed similar or
   higher bactericidal activity against a panel of P. aeruginosa
   strains. In this respect, any difference between CF sera with
   precipitins and CF sera without precipitins against P. aeurginosa was
   not found. Sera from three CF patients chronically infected with P.
   aeruginosa, and with many precipitins against these bacteria, showed
   a selective inability in bactericidal activity against the patients&apos;
   own P. aeruginosa isolate possibly reflecting the presence of
   &quot;bactericidal blocking&quot; antibodies.</abstract>

	<majorsubject>BLOOD-BACTERICIDAL-ACTIVITY</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: im</majorsubject>
	<majorsubject>PSEUDOMONAS-AERUGINOSA</majorsubject>
	<majorsubject>PSEUDOMONAS-INFECTIONS: co</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ANTIBODIES-BACTERIAL: an</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>COMPARATIVE-STUDY</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: co</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>PSEUDOMONAS-INFECTIONS: im</minorsubject>

	<reference>001   BERGAN T              ACTA PATH MICROBIOL SCAND (B)   83   553 975</reference>
	<reference>002   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971</reference>
	<reference>003   BJORNSON AB           INFECT IMMUN                     2   453 970</reference>
	<reference>004   BJORNSON AB           INFECT IMMUN                     4   462 971</reference>
	<reference>005   BJORNSON AB           INFECT IMMUN                     5   775 972</reference>
	<reference>006   BJORNSON AB           J INFECT DIS SUPPL             130   119 974</reference>
	<reference>007   BJORNSON AB           J INFECT DIS SUPPL             130   127 974</reference>
	<reference>008   BOXERBAUM B           AM REV RESPIR DIS              108   777 973</reference>
	<reference>009   CROWDER JG            J LAB CLIN MED                  83   853 974</reference>
	<reference>010   DIEM K                DOCUMENTA GEIGY SCIENTIFIC TA            962</reference>
	<reference>011   DOGGETT RG            IN: LAWSON D PROC 5TH INT CF         175 969</reference>
	<reference>012   GOLDMAN JN            INFECT DIS                     129   444 974</reference>
	<reference>013   GOVAN JRW             J MED MICROBIOL                  8   513 975</reference>
	<reference>014   GRIFFISS JM           J IMMUNOL                      114  1779 975</reference>
	<reference>015   GUTTMAN RM            CLIN EXP IMMUNOL                19   121 975</reference>
	<reference>016   HOWARD CJ             IMMUNOLOGY                      20   767 971</reference>
	<reference>017   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974</reference>
	<reference>018   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974</reference>
	<reference>019   HOIBY N               SCAND J IMMUNOL SUPPL 2          4   187 975</reference>
	<reference>020   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   83   549 975</reference>
	<reference>021   KOCH C                ACTA PATH MICROBIOL SCAND (C)   83   144 975</reference>
	<reference>022   LINDBERG U            ACTA PAEDIATR SCAND             64   432 975</reference>
	<reference>023   MARTIN DR             J MED MICROBIOL                  6   111 973</reference>
	<reference>024   MOREAU SC             SCIENCE                        190   278 975</reference>
	<reference>025   MUSCHEL LH            J IMMUNOL                       76     1 956</reference>
	<reference>026   OLLING S              INFECTION                        1    24 973</reference>
	<reference>027   REED WP               IMMUNOLOGY                      26   205 974</reference>
	<reference>028   ROWLEY D              IN: KASS E                           162 973</reference>
	<reference>029   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   83   469 975</reference>
	<reference>030   SIMBERKOFF MS         J LAB CLIN MED                  87   207 976</reference>
	<reference>031   TAYLOR PW             CLIN SCI                        43   705 972</reference>
	<reference>032   TAYLOR PW             J GEN MICROBIOL                 89    57 975</reference>
	<reference>033   TAUB WH               INFECT IMMUN                    13  1343 976</reference>
	<reference>034   WAISBREN BA           J IMMUNOL                       97   431 966</reference>
	<reference>035   YOUNG LS              J INFECT DIS                   126   257 972</reference>
	<reference>036   YOUNG LS              J INFECT DIS                   126   257 972</reference>
	<reference>037   YOUNG LS              J INFECT DIS SUPPL             130   111 974</reference>
	<reference>038   ZIERDT CH             J BACTERIOL                     87  1003 964</reference>

	<citation>1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977</citation>
	<citation>2   LARSSON P             MED MICROBIOL IMMUNOL          163    77 977</citation>
	<citation>3   LIDINJANSON G         MED MICROBIOL IMMUNOL          164   247 978</citation>
	<citation>4   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   87   229 979</citation>
	<citation>5   HODSON ME             THORAX                          35   801 980</citation>
	<citation>6   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   88   125 980</citation>
	<citation>7   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981</citation>
	<citation>8   KOEPP LH              INFECT IMMUN                    33   788 981</citation>
	<citation>9   THOMASSEN MJ          INFECT IMMUN                    33   512 981</citation>
	<citation>10   FICK RB               J CLIN INVEST                   68   899 981</citation>
	<citation>11   MARKS MI              J PEDIATR                       98   173 981</citation>
	<citation>12   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982</citation>
	<citation>13   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    63 982</citation>
	<citation>14   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982</citation>
	<citation>15   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982</citation>
	<citation>16   OFFREDOHEMMER C       ANN MICROBIOL (PARIS)         A134   281 983</citation>
	<citation>17   BOROWSKI RS           CURRENT MICROBIOL                9    25 983</citation>
	<citation>18   PENKETH ARL           J MED MICROBIOL                 16   401 983</citation>
	<citation>19   JAGGER KN             J CLIN MICROBIOL                17    55 983</citation>
	<citation>20   SCHILLER NL           PEDIATR RES                     17   747 983</citation>
	<citation>21   FICK RB               BULL EUR PHYSIOPATH RESP        19   151 983</citation>
	<citation>22   CRYZ SJ               INFECT IMMUN                    39  1072 983</citation>
	<citation>23   TAYLOR PW             MICROBIOL REV                   47    46 983</citation>
	<citation>24   PENKETH A             AM REV RESPIR DIS              127   605 983</citation>
	<citation>25   SCHILLER NL           CURRENT MICROBIOL               10   185 984</citation>
	<citation>26   MESHULAM T            CLIN IMMUNOL IMMUNOPATHOL       32   151 984</citation>
	<citation>27   KHARAZMI A            INFECT IMMUN                    43   161 984</citation>
	<citation>28   SCHILLER NL           INFECT IMMUN                    45   748 984</citation>
	<citation>29   THOMASSEN MJ          INFECT IMMUN                    45   741 984</citation>
	<citation>30   FICK RB               J CLIN INVEST                   74   236 984</citation>
	<citation>31   FALKENHAGEN U         Z UROL NEPHROL                  77   629 984</citation>
	<citation>32   PIER GB               J INFECT DIS                   150   223 984</citation>
	<citation>33   NICAS TI              EUR J CLIN MICROBIOL             4   175 985</citation>
	<citation>34   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985</citation>
	<citation>35   PAJDAK E              ARCH IMMUNOL THER EXP           33   499 985</citation>
	<citation>36   OJENIYI B             ACTA PATH MICROB IMMU SCA (B)   93     7 985</citation>
	<citation>37   SAWADA S              J INFECT DIS                   152  1290 985</citation>
	<citation>38   SCHILLER NL           INFECT IMMUN                    54   689 986</citation>
	<citation>39   FALKENHAGEN U         Z UROL NEPHROL                  79   619 986</citation>
	<citation>40   FICK RB               AM REV RESPIR DIS              133   418 986</citation>
	<citation>41   SPEERT DP             J HOSP INFECT                    9    11 987</citation>

</document>
